Prostate cancer Board decisions

The Veteran's appeal for special monthly compensation and service connection was denied due to a late filing of the Board Appeal request.

The Board has determined that the Veteran's prostate cancer may be related to herbicide exposure during service, but the AOJ's findings regarding this are unclear. The claim is remanded for further clarification.

The Board has denied service connection for sleep apnea, diabetes mellitus, emphysema, and prostate cancer as the evidence does not support a finding that these conditions began during active service or are otherwise related to an in-service injury, event, or disease.

The Board has granted readjudication of the claims for Parkinson's disease and prostate cancer based on new evidence. The claims are remanded to determine if service connection can be established due to exposure during service.

The Board has granted service connection for prostate cancer, finding that the Veteran's exposure to contaminated water at Camp Lejeune during his military service is related to his diagnosed condition. The decision resolves reasonable doubt in favor of the Veteran.

An effective date of September 27, 2024 is granted for service connection of prostate cancer.,Effective from August 10, 2022, an award of service connection for erectile dysfunction and special monthly compensation based on loss of use of a creative organ are granted.

The Board dismissed the appeal for direct payment of attorney fees based on past-due benefits awarded in May 2024, as the appellant was eligible but his claim is moot due to a calculation error and no case or controversy remains.

The Board has granted DIC benefits based on service connection for the cause of the Veteran's death, finding that his service-connected prostate cancer and its treatment caused his death due to side effects from Zytiga.

The Veteran's service connection claims for dermatitis/eczema, sleep apnea, a psychiatric disorder (including MDD and PTSD), hypertension, COPD, low back disorder, and prostate cancer are all granted. The Board found that the evidence supported these determinations based on direct service connection.

The Board has ordered a medical examination to clarify the current diagnosis of prostate disorder and determine if it is related to service, including exposure to herbicides during the Vietnam War Era.

The Veteran's hypertension and prostate cancer residuals (voiding dysfunction) have been granted increased ratings of 10 percent and 20 percent, respectively.

The Veteran is granted SMC at the rate of 50% for his service-connected conditions from April 20, 2020 to June 7, 2021.

The Board has decided to remand the claims for prostate cancer and migraines headaches due to a need for additional medical opinions regarding their etiology.

The Board denied service connection for the Servicemember's cause of death, including ALS, myasthenia gravis, and metastatic prostate cancer, as they were not incurred during or related to his military service.

The Veteran's bowel perforation disability is remanded for a VA examination to determine its etiology.,The Veteran's ulcerative colitis and obstructive sleep apnea disabilities are remanded for a VA examination to determine their etiologies.

The Board has decided to remand the case due to a need for additional information from Social Security records.

The Veteran's prostate cancer is remanded for a new VA medical opinion to address his in-service TERAs and the likelihood of a connection.

The Veteran's prostate and bladder cancer rating was reduced from 100% to 40%, effective December 1, 2025. The Veteran withdrew his appeal at a Board hearing held in April 2026.

The Board has granted effective dates of May 14, 2021 for service connection of residuals of prostate cancer and erectile dysfunction.

The Board has determined that additional development is needed due to pre-decisional errors, including the need for a VA examination and medical opinions regarding the Veteran's prostate cancer and toxic exposure risk activities.